Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma
TUESDAY, Oct. 8, 2024 (HealthDay News) — Ciltacabtagene autoleucel (cilta-cel) CAR T-cell...
Read More
Hematology/Oncology
AI May Identify Women at Risk for Future Breast Cancer
TUESDAY, Oct. 8, 2024 (HealthDay News) — Artificial intelligence (AI) scores may be able to...
Read More
Social Risk Factors Tied to Lower Odds of Receiving Preventive Services
TUESDAY, Oct. 8, 2024 (HealthDay News) — Social risk factors are associated with decreased...
Read More
American Society for Radiation Oncology, Sept. 29-Oct. 2
The annual meeting of the American Society for Radiation Oncology was held from Sept. 29 to Oct. 2...
Read More
Socioeconomic Factors Tied to Sickle Cell Complications in Preschoolers
TUESDAY, Oct. 8, 2024 (HealthDay News) — For preschool-aged children with sickle cell...
Read More
Overall Survival Improving for Umbilical Cord Blood Transplant
MONDAY, Oct. 7, 2024 (HealthDay News) — For umbilical cord blood transplant (UCBT), overall...
Read More
Liso-Cel Has Favorable Safety Profile for Outpatients With Large B-Cell Lymphoma
MONDAY, Oct. 7, 2024 (HealthDay News) — For patients with relapsed/refractory large B-cell...
Read More
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
MONDAY, Oct. 7, 2024 (HealthDay News) — A one-dose human papillomavirus (HPV) vaccination...
Read More
First-Trimester Iron Screening Can ID Women at Risk for Later Deficiency
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Screening pregnant women during their first...
Read More
Certain Oral Bacteria Tied to Risk for New Head, Neck Squamous Cell Cancer
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Certain oral bacteria are a risk factor for...
Read More
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Circulating antibodies against cancer-testis...
Read More
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Olanzapine may be better than prochlorperazine...
Read More
ASTRO: Hypofractionated Radiation Therapy Safe After Breast Reconstruction
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — For patients undergoing breast reconstruction, a...
Read More
Female Residents Underrepresented in High-Compensation Specialties
WEDNESDAY, Oct. 2, 2024 (HealthDay News) — Female physicians remain underrepresented among...
Read More
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
TUESDAY, Oct. 1, 2024 (HealthDay News) — The 2023 cisplatin shortage led to a shift in...
Read More
No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 (HealthDay News) — For patients with suspicion for prostate cancer,...
Read More
Fidanacogene Elaparvovec Superior to Prophylaxis for Hemophilia B
THURSDAY, Sept. 26, 2024 (HealthDay News) — For patients with hemophilia B, fidanacogene...
Read More
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
THURSDAY, Sept. 26, 2024 (HealthDay News) — Patients with primary thyroid cancer who receive...
Read More
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
THURSDAY, Sept. 26, 2024 (HealthDay News) — Non-Hispanic Black patients in the United States...
Read More
Childhood Trauma Tied to Worse Health, Risks Later in Life
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — Childhood adversity is associated with worse...
Read More